Wiskot-Aldrich syndrome-like lower expressed in colon cancer tissues and inhibited the stemness of human colon cancer

LI Hong-Dan; YANG Cheng

doi:10.16098/j.issn.0529-1356.2022.01.007

PDF(15745 KB)

Acta Anatomica Sinica ›› 2022, Vol. 53 ›› Issue (1) : 50-59. DOI: 10.16098/j.issn.0529-1356.2022.01.007

Cancer Biology

Wiskot-Aldrich syndrome-like lower expressed in colon cancer tissues and inhibited the stemness of human colon cancer

LI Hong-dan^1* YANG Cheng²#br#

Author information +

History +

Abstract

Objective To explore the expression of Wiskot-Aldrich syndrome-like（WASL）in colon cancer tissues and its function on colon cancer stemness. Methods The UALCAN database was used to analyze the expression of WASL in colon cancer tissues and its correlation among the gender, lymphnode stage and metastasis in colon cancer patients. Immunohistofluorescence and immunocyte fluorescence were used to verify the date from UALCAN. Western blotting was used to detect the expression and transfection efficiency of WASL in human normal colorectal mucosal cells (FHC cells) and colon cancer cells HCT-116, SW-480. Sphere formation assay and colony formation were used to detect the effect of WASL on the stemness of colon cancer. Hypoxia assay, serum deprivation, drug resistance assay were used to detect the stemness of colon cancer cells. Results WASL was lower expressed in colon cancer tissues (P<0.05). WASL was lower expressed in colon cancer tissues than peri-cancer tissues. WASL was obviously lower expressed in HCT-116 and SW-480 than FHC cells. WASL overexpression stable cells were constructed suscessfully in HCT-116 and SW-480.Real-time PCR showed WASL obviously down-regulated the expression of cancer stemcells(CSCs) related markers ［octamer binding transcription factor 4(OCT4), sex determining region Y-box 2(SOX2), Lin28, krüppel-like factor(KLF)］. Sphere formation assay and colony formation assay showed WASL could inhibited the sphere formation and colony formation. Hypoxia assay and serum deprivation showed WASL inhibited the resistance of cancer cells to hypoxia and serum deprivation. Drug resistance assay showed WASL inhibit the resistance of cancer cells to 5-fluorouracil(5-FU). Conclusion WASL is lower expressed in colon cancer tissues and cells, and is related with poor prognosis of colon cancer. Overexpression of WASL can inhibit the stemness of colon cancer cells.

Key words

Wiskot-Aldrich syndrome-like / Colon cancer / Stemness / Hypoxia / Drug resistance / Western blotting / Human

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

LI Hong-dan YANG Cheng. Wiskot-Aldrich syndrome-like lower expressed in colon cancer tissues and inhibited the stemness of human colon cancer[J]. Acta Anatomica Sinica. 2022, 53(1): 50-59 https://doi.org/10.16098/j.issn.0529-1356.2022.01.007

References

［1］ Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods ［J］. Int J Cancer, 2019, 144(8):1941-1953.

［2］ Goldberg RM, Fleming TR, Tangen CM,et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group,the North Central Cancer Treatment Group,and the Southwest Oncology Group ［J］.Ann Intern Med, 1998, 129(1):27-35.

［3］ Kuo CT, Chiang CL, Chang CH, et al.Modeling of cancer metastasis and drug resistance via biomimetic nano-cilia and microfluidics ［J］.Biomaterials, 2014, 35(5):1562-1571.

［4］ Jung P, Sommer C, Barriga FM, et al. Isolation of human colon stem cells using surface expression of PTK7 ［J］. Stem Cell Reports, 2015, 5(6):979-987.

［5］ Yan PP, Liu J, Zhou R, et al. LASP1 interacts with N-WASP to activate the Arp23 complex and facilitate colorectal cancer metastasis by increasing tumour budding and worsening the pattern of invasion ［J］.Oncogene, 2020, 39(35):5743-5755.

［6］ Hidalgo-Sastre TA, Yan P, Liu J, et al. Loss of Wasl improves pancreatic cancer outcome［J］.JCI Insight, 2020, 5(10):e127275-e127292.

［7］ Martin TA, Pereira G, Watkins G, et al. N-WASP is a putative tumour suppressor in breast cancer cells,in vitro and in vivo,and is associated with clinical outcome in patients with breast cancer ［J］. Clin Exp Metastasis, 2008, 25(2):97-108.

［8］ Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses ［J］. Neoplasia, 2017, 19(8):649-658.

［9］ Nishimura T, Nakata A, Chen XX, et al. Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2 ［J］.Oncogene, 2019, 38(14):2464-2481.

［10］ Siegel RL, Miller KD, Jemal A. Cancer statistics,2019 ［J］.CA Cancer J Clin, 2019, 69(1):7-34.

［11］ Stein A, Folprecht G. Immunotherapy of colon cancer ［J］.Oncol Res Treat, 2018, 41(5):282-285.

［12］ Huang JZ, Chen M, Chen D, et al. A peptide encoded by a putative lncRNA HOXB-AS3 suppresses colon cancer growth［J］.Mol Cell, 2017, 68(1):171-184.

［13］ Yuan YN, Du MN, Yan XL, et al. Expression of miR-145-5p in colorectal cancer and its relationship with multidrug resistance ［J］. Acta Anatomica Sinica，2020,51(4):553-556. (in Chinese)

袁亚男，杜梦楠，严晓丽，等. MiR-145-5p 在大肠癌中的表达及与多药耐药的关系［J］. 解剖学报，2020，51（4）:553-556.

［14］ Zhang TJ, Han S, Zhang W, et al. Triptolide promoting colon cancer CT26 cell death through induction of autophagy ［J］. Acta Anatomica Sinica, 2016, 47(6): 774-778. (in Chinese)

张天娇，韩森，张玮，等. 雷公藤甲素通过诱导细胞自噬促进结肠癌CT26细胞死亡［J］. 解剖学报，2016，47（6）: 774-778.

［15］ Li H, Courtois ET, Sengupta D, et al. Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors ［J］. Nat Genet, 2017, 49(5): 708-718.

［16］ Morris HT, Fort L, Spence HJ, et al. Loss of N-WASP drives early progression in an Apc model of intestinal tumourigenesis ［J］. J Pathol, 2018, 245(3):337-348.

［17］ Sanchez AM, Flamini MI, Baldacci C, et al. Estrogen receptor-alpha promotes breast cancer cell motility and invasion via focal adhesion kinase and N-WASP ［J］. Mol Endocrinol, 2010, 24(11):2114-2125.

［18］ Jin KM, Lu D, Liu FF, et al. N-WASP is highly expressed in hepatocellular carcinoma and associated with poor prognosis ［J］.Surgery, 2013, 153(4):518-525.

［19］ Liu GH, Chen J, Ji ZG, et al.Expression of neural Wiskott-Aldrich syndrome protein in clear cell renal cell carcinoma and its correlation with clinicopathological features ［J］.Urol Int, 2015, 95(1):79-85.